Imagen de Portada

Insulin requirements after switching from GLP ‐1 receptor agonist to dual GIP / GLP ‐1 receptor agonist in patients with type 2 diabetes mellitus

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Alexa M. Lahey, Karolyn Duprey, Riley C. Montague, Aric D. Schadler, Kristina W. Naseman
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Real‐World Cardiovascular Outcomes of GLP ‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
por: Cyrille K. Cornelio, et al.
Publicado: (2026)

GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis
por: Levi Hooper, et al.
Publicado: (2025)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
por: Erin F. Barreto, et al.
Publicado: (2026)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
por: Aya M. AbdelMagid, et al.
Publicado: (2026)

Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials
por: Satoru Mitsuboshi, et al.
Publicado: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
por: Nicholas C. Tonial, et al.
Publicado: (2025)

Intravenous Regular Insulin for Treatment of Hyperkalemia in Overweight Patients
por: Denise Kelley, et al.
Publicado: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
por: Hua‐Ping Fan, et al.
Publicado: (2024)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
por: Christen J. Arena, et al.
Publicado: (2025)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
por: Casey L. Keller, et al.
Publicado: (2026)

Lactated Ringer's versus normal saline in the management of acute diabetic ketoacidosis (RINSE‐DKA)
por: Auriene Jamison, et al.
Publicado: (2024)

Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
por: Kellye Eagan, et al.
Publicado: (2025)

Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea
por: Hee‐Jin Kim, et al.
Publicado: (2025)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
por: Mennatullah Hasan, et al.
Publicado: (2024)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
por: Lena Makortoff, et al.
Publicado: (2024)

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
por: Stephanie Shabanowitz, et al.
Publicado: (2026)

Precision Daptomycin Dosing: Comparison of 3‐, 2‐, 1‐, and 0‐Concentration Sample Strategies
por: Simone Giuliano, et al.
Publicado: (2025)

Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease
por: Tien‐Jyun Chang, et al.
Publicado: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
por: Mohammed Aldhaeefi, et al.
Publicado: (2024)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
por: Caroline Chen, et al.
Publicado: (2025)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
por: David B. Cluck, et al.
Publicado: (2024)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
por: Elizabeth M. Sherman, et al.
Publicado: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
por: Alexandre Duong, et al.
Publicado: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
por: Maryam Aghakouchakzadeh, et al.
Publicado: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
por: Seonga Song, et al.
Publicado: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
por: Mohammed Al Musawa, et al.
Publicado: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: Atif Siddiqui
Publicado: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
por: Jiwon Kim, et al.
Publicado: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
por: Keith A. Rodvold
Publicado: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
por: Nicolette Centanni, et al.
Publicado: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
por: Yi‐Fan Chien, et al.
Publicado: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
por: Amanda Massmann, et al.
Publicado: (2025)

In Search of Big Beautiful Biomarkers
por: C. Lindsay DeVane
Publicado: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
por: Lisa T. Hong, et al.
Publicado: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
por: Nihal El Rouby, et al.
Publicado: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
por: Trisha Matsuura, et al.
Publicado: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
por: Amira R. Rashdan, et al.
Publicado: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
por: Kathleen A. Stringer, et al.
Publicado: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
por: Shibing Tao, et al.
Publicado: (2024)